3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Large B-Cell, Diffuse
44
Breast Neoplasms
30
Lymphoma
29
Sarcoma
27
Hodgkin Disease
24
Triple Negative Breast Neoplasms
20
Burkitt Lymphoma
20
Precursor Cell Lymphoblastic Leukemia-Lymphoma
19
Neoplasms
15
Lymphoma, Follicular
15
Ovarian Neoplasms
14
Lymphoma, B-Cell
14
Lymphoma, Non-Hodgkin
13
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
9
Lymphoma, T-Cell, Peripheral
9
Endometrial Neoplasms
9
Neuroblastoma
7
Neoplasm Metastasis
7
Lymphoma, Mantle-Cell
7
Liposarcoma
7
Leukemia
7
Fallopian Tube Neoplasms
7
Recurrence
6
Multiple Myeloma
6
Leiomyosarcoma
6
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
5
Osteosarcoma
5
Lymphoma, B-Cell, Marginal Zone
5
Leukemia, Lymphocytic, Chronic, B-Cell
5
Inflammatory Breast Neoplasms
5
Interventions
Specimen Handling
8
Tamoxifen
6
Standard of Care
4
Practice Guidelines as Topic
4
Radiotherapy
3
Methods
3
Sentinel Lymph Node Biopsy
2
Radiation Dose Hypofractionation
2
Radiation
2
Educational Status
2
Early Intervention, Educational
2
Counseling
2
ruxolitinib
1
pembrolizumab
1
exemestane
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
auricularum
1
abemaciclib
1
Watchful Waiting
1
Telemedicine
1
Taxes
1
Tablets
1
Surveys and Questionnaires
1
Starch
1
Reverse Transcriptase Polymerase Chain Reaction
1
Ranitidine
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Conformal
1
Radiosurgery
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Breast Carcinoma In Situ
×
Doxorubicin
×
1 year
×
Clear all
No trials found.